<?xml version="1.0"?><rss version="2.0"><channel><title>drug development - Latest News</title><link>http://news.prlog.org/tag/drug-development/</link><description>drug development - Latest News (Press Releases) - Read news before it's news</description><language>en-us</language><ttl>3600</ttl>
<item><title>Innovative Screening Method Uses RNA Interference Technology to Identify Lethal and Rescuer Genes</title><link>http://www.prlog.org/12138862-innovative-screening-method-uses-rna-interference-technology-to-identify-lethal-and-rescuer-genes.html</link><description>New Rochelle, May 16, 2013–Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively.</description></item>
<item><title>Veristat and Certara Expand Service Offerings with New Partnership</title><link>http://www.prlog.org/12136615-veristat-and-certara-expand-service-offerings-with-new-partnership.html</link><description>Collaboration offers clients more streamlined and efficient approach to trial planning</description></item>
<item><title>Identifying inhibitors of human proteins that promote tumor formation</title><link>http://www.prlog.org/12131043-identifying-inhibitors-of-human-proteins-that-promote-tumor-formation.html</link><description>Tumor repressor genes, which inhibit tumor formation, can be &quot;turned off&quot; due to undesirable molecular changes affecting the chromosomes on which the genes reside.</description></item>
<item><title>The latest breakthroughs in Adaptive Designs in Clinical Trials</title><link>http://www.prlog.org/12107244-the-latest-breakthroughs-in-adaptive-designs-in-clinical-trials.html</link><description>Adaptive Designs in Clinical Trials to take place in London, UK, 8th &amp; 9th April...</description></item>
<item><title>Three Plenary Keynotes to Take Place at 12th Annual Bio-IT World Expo</title><link>http://www.prlog.org/12102715-three-plenary-keynotes-to-take-place-at-12th-annual-bio-it-world-expo.html</link><description>Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge...</description></item>
<item><title>Webinar to Focus on Rare Disease Drug Development</title><link>http://www.prlog.org/12101685-webinar-to-focus-on-rare-disease-drug-development.html</link><description>Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...</description></item>
<item><title>Calvert Labs and Particle Sciences Partner to Streamline Early-Stage Drug Development</title><link>http://www.prlog.org/12096552-calvert-labs-and-particle-sciences-partner-to-streamline-early-stage-drug-development.html</link><description>Scott Township, PA – Calvert Laboratories and Particle Sciences, two leading companies in their respective fields of preclinical toxicology and drug product formulation, announced today that they have joined forces to offer a streamlined solution to...</description></item>
<item><title>Dr. Pierre Maison-Blanche appointed as New Chief Medical Officer of Cardiabase</title><link>http://www.prlog.org/12081846-dr-pierre-maison-blanche-appointed-as-new-chief-medical-officer-of-cardiabase.html</link><description>CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer.</description></item>
<item><title>Two Plenary Keynote Panels to be Delivered at 20th Annual Molecular Medicine Tri-Conference</title><link>http://www.prlog.org/12069954-two-plenary-keynote-panels-to-be-delivered-at-20th-annual-molecular-medicine-tri-conference.html</link><description>Plenary Keynote Panels on &quot;Personalized Oncology: Fulfilling the Promise for Today’s Patients&quot; and &quot;Emerging Technologies &amp; Industry Perspectives&quot; to be Delivered Next Month in San Francisco</description></item>
<item><title>Imaging in Cancer Drug Development: Clinical Application and Innovation – 13-14 March 2013</title><link>http://www.prlog.org/12068892-imaging-in-cancer-drug-development-clinical-application-and-innovation-13-14-march-2013.html</link><description>Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development.</description></item>
<item><title>Molecular Medicine Tri-Conference 2013 - Complimentary Hall Passes Now Available</title><link>http://www.prlog.org/12066138-molecular-medicine-tri-conference-2013-complimentary-hall-passes-now-available.html</link><description>Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference</description></item>
<item><title>CHI Announces its Patient-Derived Cancer Tissue Xenograft Models Short Course</title><link>http://www.prlog.org/12062192-chi-announces-its-patient-derived-cancer-tissue-xenograft-models-short-course.html</link><description>Cambridge Healthtech Institute's Patient-Derived Cancer Tissue Xenograft Models Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.</description></item>
<item><title>ACR Image Metrix™ Chooses Adaptive Clinical Systems’ Cloud-Based Services For e-Clinical Support</title><link>http://www.prlog.org/12038285-acr-image-metrix-chooses-adaptive-clinical-systems-cloud-based-services-for-clinical-support.html</link><description>ACRIM, a leading imaging Contract Research Organization (iCRO), has selected Adaptive Clinical Systems’ Cloud-based e-Clinical solution for its EDC needs.</description></item>
<item><title>Cholesterol removal from serum samples using Cleanascite™ for vaccine research</title><link>http://www.prlog.org/12034699-cholesterol-removal-from-serum-samples-using-cleanascite-for-vaccine-research.html</link><description>Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine.</description></item>
<item><title>Bio-IT World Expo Announces 2013 Keynote Speakers</title><link>http://www.prlog.org/12034013-bio-it-world-expo-announces-2013-keynote-speakers.html</link><description>International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston</description></item>
<item><title>Paediatric legislation: Challenges and Impact on Drug Development</title><link>http://www.prlog.org/11748327-paediatric-legislation-challenges-and-impact-on-drug-development.html</link><description>EU regulations on paediatric drug development are becoming more and more complicated and pharmaceutical companies have to prepare more robust and detailed paediatric investigation plans to ensure the success of their clinical trials</description></item>
<item><title>PATH’s Drug Development program announces positive phase 1 results for its anti-diarrheal drug</title><link>http://www.prlog.org/12021206-paths-drug-development-program-announces-positive-phase-1-results-for-its-anti-diarrheal-drug.html</link><description>PATH's Drug Development program has developed a new medication to treat diarrhea. This new drug treats the diarrheal process to shorten its duration.</description></item>
<item><title>Dr. Arthur Lo, Theravance, to Discuss a Viral Kinetics Modeling Rosa’s Impact Webinar Series</title><link>http://www.prlog.org/12017591-dr-arthur-lo-theravance-to-discuss-viral-kinetics-modeling-rosas-impact-webinar-series.html</link><description>Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on November 14, 2012.</description></item>
<item><title>Dr. Toufigh Gordi to discuss the Selection of Appropriate Modeling Techniques in Drug Development</title><link>http://www.prlog.org/12017589-dr-toufigh-gordi-to-discuss-the-selection-of-appropriate-modeling-techniques-in-drug-development.html</link><description>Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process at 4th World PK/PD Summit on November 28, 2012 in Frankfort, Germany</description></item>
<item><title>CHI Releases Final Agenda for Ninth Annual microRNA Conference</title><link>http://www.prlog.org/12016007-chi-releases-final-agenda-for-ninth-annual-microrna-conference.html</link><description>Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development</description></item>
<item><title>Leaders to Discuss Growing Trend of Drug Repositioning at 2nd Annual Drug Repositioning Conference</title><link>http://www.prlog.org/11985711-leaders-to-discuss-growing-trend-of-drug-repositioning-at-2nd-annual-drug-repositioning-conference.html</link><description>The 2nd Annual Drug Repositioning and Indications Discovery Conference is being held on October 23-24, 2012 in San Francisco, CA. This conference will feature a variety of speakers from academia, industry, non-profits and government.</description></item>
<item><title>Avacta extends Pall Life Sciences’ Optim 1000 distribution agreement to include India</title><link>http://www.prlog.org/11985639-avacta-extends-pall-life-sciences-optim-1000-distribution-agreement-to-include-india.html</link><description>Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market</description></item>
<item><title>Knowledge Management At The Early Drug Development Summit</title><link>http://www.prlog.org/11982172-knowledge-management-at-the-early-drug-development-summit.html</link><description>We’re pleased to announce that Andreas Schneider, Vice President Life Science Alliances, Roche, will be speaking at the Early Drug Development Summit, 3rd - 4th December 2012 at the Hotel Palace Berlin, Germany.</description></item>
<item><title>Delivering Innovation and Efficiency through Adaptive Clinical Trials</title><link>http://www.prlog.org/11971998-delivering-innovation-and-efficiency-through-adaptive-clinical-trials.html</link><description>Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development.</description></item>
<item><title>Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Webinar Series</title><link>http://www.prlog.org/11968776-dr-malcolm-rowland-to-discuss-physiologically-based-pharmacokinetics-in-rosas-webinar-series.html</link><description>Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012</description></item>
<item><title>Drug Development Requires Flexibility In Clinical Trial Design: ICRC-Weyer Clinical CRO Interview</title><link>http://www.prlog.org/11953840-drug-development-requires-flexibility-in-clinical-trial-design-icrc-weyer-clinical-cro-interview.html</link><description>Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation.</description></item>
<item><title>Ascites fluid and cell culture clarification via Cleanascite™ for monoclonal antibody purification</title><link>http://www.prlog.org/11947852-ascites-fluid-and-cell-culture-clarification-via-cleanascite-for-monoclonal-antibody-purification.html</link><description>Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification</description></item>
<item><title>Urine Protein Enrichment From Diabetic Urine Samples With UPCK™ Urine Protein Enrichment Kit</title><link>http://www.prlog.org/11947848-urine-protein-enrichment-from-diabetic-urine-samples-with-upck-urine-protein-enrichment-kit.html</link><description>UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples</description></item>
<item><title>OneWorld Health names Dr. Ponni Subbiah new global program leader</title><link>http://www.prlog.org/11931426-oneworld-health-names-dr-ponni-subbiah-new-global-program-leader.html</link><description>Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader.</description></item>
<item><title>New Book on the Design and Analysis of Bridging Studies from CRC Press</title><link>http://www.prlog.org/11929251-new-book-on-the-design-and-analysis-of-bridging-studies-from-crc-press.html</link><description>Covers the regulatory requirements, scientific and practical issues, and statistical methodology for designing and evaluating bridging studies and multiregional clinical trials, with the goal of inspiring new research activities in the field.</description></item>
<item><title>Dr. Scott Siler to Discuss DILIsym Model in Rosa’s Impact Webinar Series</title><link>http://www.prlog.org/11889127-dr-scott-siler-to-discuss-dilisym-model-in-rosas-impact-webinar-series.html</link><description>Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012</description></item>
<item><title>Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s Webinar Series, “Impact of M&amp;S&quot;</title><link>http://www.prlog.org/11876281-dr-toufigh-gordi-to-discuss-pediatric-pk-model-in-rosas-webinar-series-impact-of-ms.html</link><description>Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012.</description></item>
<item><title>Banook expands into central imaging services for clinical trials</title><link>http://www.prlog.org/11860918-banook-expands-into-central-imaging-services-for-clinical-trials.html</link><description>Banook, a leading clinical trial service provider, is pleased to announce the launch of Banook Central Imaging (www.banook-ci.com), a global service organization providing medical imaging services for clinical research area.</description></item>
<item><title>Dr. Birgit Schoeberl to Present in Rosa’s &quot;Impact&quot; World-Wide Webinar Series</title><link>http://www.prlog.org/11837556-dr-birgit-schoeberl-to-present-in-rosas-impact-world-wide-webinar-series.html</link><description>Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012.</description></item>
<item><title>CHI Releases Conference Proceedings CD from Molecular Medicine Tri-Conference 2012</title><link>http://www.prlog.org/11836103-chi-releases-conference-proceedings-cd-from-molecular-medicine-tri-conference-2012.html</link><description>Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery &amp; development, informatics and cancer. TriConference.com</description></item>
<item><title>Rosa Announces Publication of its PhysioPD Model Qualification Method and Series of Educational Even</title><link>http://www.prlog.org/11810410-rosa-announces-publication-of-its-physiopd-model-qualification-method-and-series-of-educational-even.html</link><description>Series of Seminars and Workshops to be held in 2012 across the US and in Europe</description></item>
<item><title>Drug Development:Vela Laboratories and Anagnostics enter strategic partnership</title><link>http://www.prlog.org/11794539-drug-developmentvela-laboratories-and-anagnostics-enter-strategic-partnership.html</link><description>Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.</description></item>
<item><title>CHI Announces Challenges of Targeting Cancer Stem Cells at Cancer Biologics 2012</title><link>http://www.prlog.org/11792904-chi-announces-challenges-of-targeting-cancer-stem-cells-at-cancer-biologics-2012.html</link><description>Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.</description></item>
<item><title>Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development</title><link>http://www.prlog.org/11789000-biopontis-alliance-fund-and-rosa-announce-strategic-relationship-for-early-stage-drug-development.html</link><description>Collaboration will combine Rosa’s PhysioPD™ modeling &amp; simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity</description></item>
<item><title>CHI Announces Technological Challenges with Antibody Drug Conjugates at Cancer Biologics 2012</title><link>http://www.prlog.org/11782678-chi-announces-technological-challenges-with-antibody-drug-conjugates-at-cancer-biologics-2012.html</link><description>A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.</description></item>
<item><title>CHI Announces a Pre-clinical Assessment for Prediction of Clinical Success for Cancer Biologics</title><link>http://www.prlog.org/11776706-chi-announces-pre-clinical-assessment-for-prediction-of-clinical-success-for-cancer-biologics.html</link><description>A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.</description></item>
<item><title>Cambridge Healthtech Institute Announces Featured Presentations at Cancer Biologics 2012</title><link>http://www.prlog.org/11775732-cambridge-healthtech-institute-announces-featured-presentations-at-cancer-biologics-2012.html</link><description>CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.</description></item>
<item><title>Core research &amp; development services integral to global pharmaceutical outsourcing</title><link>http://www.prlog.org/11774090-core-research-development-services-integral-to-global-pharmaceutical-outsourcing.html</link><description>Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&amp;D) services such as drug development and clinical trials through strategic third-party collaborative partnerships.</description></item>
<item><title>Plenary Keynote Line Up at the Upcoming Molecular Medicine Tri-Conference</title><link>http://www.prlog.org/11770888-plenary-keynote-line-up-at-the-upcoming-molecular-medicine-tri-conference.html</link><description>Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference</description></item>
<item><title>ReportsnReports.com: New Emerging R&amp;D Locations</title><link>http://www.prlog.org/11770454-reportsnreportscom-new-emerging-rd-locations.html</link><description>Business Insight’s new report “New Emerging R&amp;D Locations” is now available at ReportsnReports.com.</description></item>
<item><title>Breakout Discussion Groups at CHI's Oncology Clinical Trials Event Next Month in San Francisco</title><link>http://www.prlog.org/11769763-breakout-discussion-groups-at-chis-oncology-clinical-trials-event-next-month-in-san-francisco.html</link><description>Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).</description></item>
<item><title>ReportsnReports.com: Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug</title><link>http://www.prlog.org/11765445-reportsnreportscom-evolution-in-the-pain-therapy-drugs-market-nociceptive-and-neuropathic-drug.html</link><description>Espicom Limited’s new report “Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug Development” is now available at ReportsnReports.com.</description></item>
<item><title>8th Annual Translational Science Event Only 7 Weeks Away!</title><link>http://www.prlog.org/11764815-8th-annual-translational-science-event-only-7-weeks-away.html</link><description>Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!</description></item>
<item><title>ReportsnReports.com: Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market</title><link>http://www.prlog.org/11762430-reportsnreportscom-outsourcing-in-drug-development-the-contract-research-clinical-trials-market.html</link><description>Kalorama Information’s new report “Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market” is now available at ReportsnReports.com.</description></item>
<item><title>SMi’s 6th annual Paediatric Clinical Trials held on 21st &amp; 22nd March 2012, London</title><link>http://www.prlog.org/11723339-smis-6th-annual-paediatric-clinical-trials-held-on-21st-22nd-march-2012-london.html</link><description>Paediatric vaccine development: Some key clinical trials - their design, execution and ethics</description></item></channel></rss>